Abstract
Introduction: Treatment of cervical dystonia (CD) with the highly purified Botulinum neurotoxin type A (BTX-A) free of complexing proteins (Xeomin) is mainly based on the largest controlled study of BTX-A ever performed (Benecke et al. 2005) demonstrating that Xeomin is non-inferior to Botox and that in average the efficacy of one Xeomin unit is equivalent to one Botox unit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
